Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

153 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

NCT04846920

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Beth Israel Deaconess Medical Center ( Site 1002) Boston, Massachusetts, United States
  • University of Michigan ( Site 1006) Ann Arbor, Michigan, United States
  • Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center-Genitourinary Medical Oncology ( Site 1007) Houston, Texas, United States
View Trial Details
Completed

Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma

NCT00720941

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Novartis Investigative Site Huntsville, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Beverly Hills, California, United States
View all 227 locations
View Trial Details
Completed

Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma

NCT01147822

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Nanjing, Jiangsu, China
  • Novartis Investigative Site Hangzhou, Zhejiang, China
  • Novartis Investigative Site Beijing, China
View all 21 locations
View Trial Details
Completed

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

NCT03138512

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Local Institution - 0019 Birmingham, Alabama, United States
  • Local Institution - 0056 Springdale, Arkansas, United States
  • Local Institution - 0186 Los Angeles, California, United States
  • Local Institution - 0180 Los Angeles, California, United States
View all 200 locations
View Trial Details
Completed

A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

NCT01672775

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Site US00005 University of Michigan Medical Center Ann Arbor, Michigan, United States
  • Site US00003 Karmanos Cancer Institute Detroit, Michigan, United States
  • Site US00004 Roswell Park Cancer Institute Buffalo, New York, United States
  • Site US00002 Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions